Nivolumab: Targeting PD-1 to bolster antitumor immunity

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Nivolumab: Targeting PD-1 to bolster antitumor immunity'. Together they form a unique fingerprint.

Medicine & Life Sciences